Advancements in machine learning are reshaping protein structure prediction, offering efficient tools that enhance drug ...

Artificial intelligence (AI) is a rapidly evolving field, and there are many exciting developments happening all the time. Here are a few recent ...

Former DeepMind scientist Simon Kohl has raised $50 million for Latent Labs, a London-based AI startup aiming to transform ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

AI accelerates drug development, cutting costs and boosting success rates. Discover how AI is reshaping the future of ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

President of IBM discussed need for ‘transparent, explainable AI’ and called for regulation of applications not algorithms ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

New government-funded fellowships will see researchers explore how AI can change the way we conduct research while 23 ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.